VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

Influenza virus DNA vaccine pHA/NP147–155 encoding NP147-155
Vaccine Information
  • Vaccine Name: Influenza virus DNA vaccine pHA/NP147–155 encoding NP147-155
  • Target Pathogen: Influenza virus
  • Target Disease: Influenza (flu)
  • Vaccine Ontology ID: VO_0004302
  • Type: DNA vaccine
  • Status: Research
  • Host Species as Laboratory Animal Model: Mouse
  • NP gene engineering:
    • Type: DNA vaccine construction
    • Description: Vector pVAX1 expressed nucleoprotein (NP) specific CTL epitope (NP147–155) (Tao et al., 2009).
    • Detailed Gene Information: Click Here.
  • HA gene engineering:
    • Type: DNA vaccine construction
    • Description: Vector pVAX1 expressed surface proteins hemagglutinin (HA) (Tao et al., 2009).
    • Detailed Gene Information: Click Here.
  • DNA vaccine plasmid:
    • DNA vaccine plasmid name:
    • DNA vaccine plasmid VO ID: VO_0000024
  • Immunization Route: Intramuscular injection (i.m.)
Host Response

Mouse Response

  • Vaccine Immune Response Type: VO_0000286
  • Efficacy: Mice vaccinated with pHA/NP147–155 had significantly reduced lung viral titers, compared with control mice vaccinated with the pVAX1vector. Our data showed that vaccination of mice with pHA/NP147–155 induced the enhanced protection against H5N1 influenza virus infection in BALB/c mice, suggesting that it is feasible to use DNA vaccines that express multiple epitopes to fight against H5N1 influenza viruses. the enhanced protection against the H5N1 influenza virus by pHA/NP147–155 vaccination was dependent on the recognition of the H-2d dominant CD8+ T cell epitope in mice (Tao et al., 2009).
References
Tao et al., 2009: Tao P, Luo M, Pan R, Ling D, Zhou S, Tien P, Pan Z. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice. Antiviral research. 2009; 81(3); 253-260. [PubMed: 19135483].